Lisata Therapeutics, Inc. (LSTA)
1.05
+0.01
(+0.96%)
USD |
NASDAQ |
Oct 21, 16:00
1.05
0.00 (0.00%)
After-Hours: 17:53
Lisata Therapeutics Price to Book Value : 1.161 for Oct. 21, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 20, 2026 | 1.150 |
| October 19, 2026 | 1.106 |
| October 16, 2026 | 1.139 |
| October 15, 2026 | 1.184 |
| October 14, 2026 | 1.128 |
| October 13, 2026 | 1.195 |
| October 12, 2026 | 1.161 |
| October 09, 2026 | 1.172 |
| October 08, 2026 | 1.327 |
| October 07, 2026 | 1.294 |
| October 06, 2026 | 1.338 |
| October 05, 2026 | 1.394 |
| October 02, 2026 | 1.626 |
| October 01, 2026 | 1.648 |
| September 30, 2026 | 1.593 |
| September 29, 2026 | 1.626 |
| September 28, 2026 | 1.659 |
| September 25, 2026 | 1.748 |
| September 24, 2026 | 1.659 |
| September 23, 2026 | 1.587 |
| September 22, 2026 | 1.637 |
| September 21, 2026 | 1.726 |
| September 18, 2026 | 1.880 |
| September 17, 2026 | 1.925 |
| September 16, 2026 | 1.626 |
| Date | Value |
|---|---|
| September 15, 2026 | 1.704 |
| September 14, 2026 | 1.726 |
| September 11, 2026 | 1.803 |
| September 10, 2026 | 1.814 |
| September 09, 2026 | 2.102 |
| September 08, 2026 | 2.057 |
| September 04, 2026 | 1.825 |
| September 03, 2026 | 1.814 |
| September 02, 2026 | 1.737 |
| September 01, 2026 | 1.737 |
| August 31, 2026 | 1.648 |
| August 28, 2026 | 1.869 |
| August 27, 2026 | 2.013 |
| August 26, 2026 | 2.002 |
| August 25, 2026 | 1.925 |
| August 24, 2026 | 1.947 |
| August 21, 2026 | 1.714 |
| August 20, 2026 | 1.239 |
| August 19, 2026 | 1.239 |
| August 18, 2026 | 1.272 |
| August 17, 2026 | 1.195 |
| August 14, 2026 | 1.206 |
| August 13, 2026 | 1.250 |
| August 12, 2026 | 1.305 |
| August 11, 2026 | 1.338 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.661 |
| Alnylam Pharmaceuticals, Inc. | 22.23 |
| Anika Therapeutics, Inc. | 2.004 |
| Savara, Inc. | 6.670 |
| Vericel Corp. | 5.668 |
Price to Book Value Related Metrics
| PS Ratio | 93.67 |
| Price | 1.05 |
| Earnings Yield | -156.3% |
| Market Cap | 9.575M |